Clinical Trial Update: Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I dose-finding study of melatonin in pediatric patients with relapsed solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: C17 Council | Conditions: Relapsed Malignant Solid Tumor | Phase 1 | Status: COMPLETED